| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/20/2005 | CN1640488A Method for preparing supermicro powder preparation of cordyceps sinensis mycelium |
| 07/20/2005 | CN1640452A Use of manchurian tuber gourd fruit extract for preparing analgesic, anti-inflammatory and/or anti-allergic medicine |
| 07/20/2005 | CN1640444A Fresh tea juice preparation and its preparing method |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211125C Olopatadine formulations for topical administration |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/20/2005 | CN1211121C Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis B surface antigen, and prepn. method thereof |
| 07/20/2005 | CN1211107C Mixture for improving blood circulation |
| 07/20/2005 | CN1211095C Blood pressure lowering and heart protectint tablet |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/20/2005 | CN1211080C Method for preparing microcapsule |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919458 Preparation of terfenadine carboxylic acid metabolite and carebastine using a 1-(2-substituted isopropyl)-4-(cyclopropylcarbonyl)-benzene compound intermediate |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919361 Five-membered-ring compound |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors |
| 07/19/2005 | US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/19/2005 | US6919344 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919335 Heterocycles that are inhibitors of IMPDH enzyme |
| 07/19/2005 | US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents |
| 07/19/2005 | US6919317 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role |
| 07/19/2005 | US6919316 Administering to a subject in need, an immunosuppressively effective amount of at least one sulfofucosylacylglycerol compound |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919086 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 07/19/2005 | US6919081 Lak activity potentiator orginating in shitake mushroom hyphae extract and lak activity potentiating preparations containing the same |
| 07/19/2005 | US6919079 FcεPE chimeric protein for targeted treatment of allergy responses, a method for its production and pharmaceutical compositions containing the same |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063725A1 Phenylpropanoic acid derivatives |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063264A1 Immunopotentiator and method of enhancing immunological activity with the same |
| 07/14/2005 | WO2005026210A3 Therapeutic binding molecules |
| 07/14/2005 | WO2005009480A3 Implants containing codrugs |
| 07/14/2005 | WO2004058770A8 Triptolide derivatives and their use |
| 07/14/2005 | WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050155087 Method of screening compounds |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050154190 compounds obtained by the screening of the present invention are useful as agents for the prevention/treatment of, for example, neurodegenerative diseases, immunological diseases, edema, acid indigestion, etc. |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050154016 Preventives for hiv infection |
| 07/14/2005 | US20050154015 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050153997 Fredericamycin derivatives |
| 07/14/2005 | US20050153992 Glycogen synthase kinase-3 inhibitors; pyrrolo[3,2-d]pyrimidine: neurodegenerative diseases; antidiabetic, antiinflammatory, anticancer agents; 5-(2-aminoethyl)-6-(3-chloro(2-thienyl))-7-iodo-3-hydropyrrolo[3,2-d]pyrimidin-4-thione Trifluoroacetate; 4-halo intermediates |
| 07/14/2005 | US20050153973 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; enzyme inhibitors; diabetes |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153957 Beta2-adrenoceptor agonists |
| 07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
| 07/14/2005 | US20050153889 Modulation of pericyte proliferation |
| 07/14/2005 | US20050153367 Method of detecting immune response |
| 07/14/2005 | US20050153018 pellets comprising compacted inner matrices containing viable microorganisms and moisture barrier coatings |
| 07/14/2005 | US20050152985 The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system. |
| 07/14/2005 | US20050152966 For controlled release of lyophilized probiotic bacterium; compressed tablets |
| 07/14/2005 | US20050152930 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152894 Antibodies with altered effector functions |
| 07/14/2005 | US20050152873 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct |
| 07/14/2005 | US20050152845 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form |
| 07/14/2005 | DE10018681B4 Therapeutisches Mittel für die autologe Immuntherapie von Tumoren sowie Verfahren zur Herstellung eines solchen Mittels A therapeutic agent for autologous immunotherapy of tumors as well as methods for preparing such an agent |
| 07/14/2005 | CA2704300A1 Cd40 antibody formulation and methods |
| 07/14/2005 | CA2552155A1 Use of il-18 binding protein in inflammations |
| 07/14/2005 | CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same |
| 07/14/2005 | CA2551008A1 Anti-cd40 antibody mutants |
| 07/14/2005 | CA2550998A1 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/14/2005 | CA2550435A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | CA2550375A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | CA2550309A1 Canine probiotic bifidobacteria pseudolongum |
| 07/14/2005 | CA2550307A1 Canine probiotic bifidobacteria globosum |
| 07/14/2005 | CA2545324A1 Aminoglycoside antibiotics for use as vap-1/ssao inhibitors |
| 07/13/2005 | EP1553098A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 07/13/2005 | EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore |
| 07/13/2005 | EP1553096A1 Pyrazole compounds |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1552851A1 Rapidly disintegrating tablet and process for producing the same |
| 07/13/2005 | EP1552844A1 Botanical extract composition |
| 07/13/2005 | EP1552842A1 Bicyclic pyrimidine derivatives |
| 07/13/2005 | EP1552838A1 Rubrofusarin glycoside-containing composition |
| 07/13/2005 | EP1552829A1 Derivatives of triptolide having high immunosuppressive effect and high water solubility, and uses thereof |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1552018A2 Methods and compositions relating to gene silencing |
| 07/13/2005 | EP1551985A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551877A2 Taci antibodies and uses thereof |
| 07/13/2005 | EP1551875A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551865A2 Hybrid molcules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 07/13/2005 | EP1551848A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 07/13/2005 | EP1551841A1 Pyrazolopyrimidines as kinase inhibitors |
| 07/13/2005 | EP1551837A1 Phosphodiesterase 4 inhibitors |
| 07/13/2005 | EP1551791A1 Novel salt forms of poorly soluble probucol esters and ethers |
| 07/13/2005 | EP1551763A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |